Takeda Pharmaceutical TAK
NYSE TAK
$18.48 -0.42 (-2.22%)
As of: Sep 29, 2026 · 3:59 PM EDT

Takeda Pharmaceutical (TAK) FCF Margin (2018 - 2026)

Updated

Takeda Pharmaceutical's FCF Margin was 14.87% in the quarter ended Jun 30, 2026, down 8.92 percentage points from 23.80% a year earlier and down 6.58 percentage points from the prior quarter.

Analysis

Takeda Pharmaceutical (TAK) FCF Margin (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Takeda Pharmaceutical's FCF Margin was 26.54% through Jun 30, 2026, down 0.12 percentage points year-over-year; for the year ended Mar 31, 2026, it was 27.02%, down 0.44 percentage points from the prior year.

  • FCF Margin shows a five-year change of -8.07 percentage points (years ended Mar 2021 to Mar 2026).
  • In earlier years, FCF Margin was 27.46% in the year ended Mar 31, 2025 (+6.54 pp), 20.91% in the year ended Mar 31, 2024 (-6.84 pp), 27.75% in the year ended Mar 31, 2023 (-7.17 pp) and 34.92% in the year ended Mar 31, 2022 (-0.17 pp).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly FCF Margin since the quarter ended Jun 30, 2023.
  • Compared with a year earlier, FCF Margin has declined for three straight quarters, with an average year-over-year change of +3.16 percentage points over the last eight quarters.
  • The best year-over-year quarter for FCF Margin over five years was the quarter ended Dec 31, 2024 (a gain of 22.29 percentage points); the worst was the quarter ended Sep 30, 2023 (a drop of 55.05 percentage points).
  • Per Business Quant data, TAK's FCF Margin in the three quarters before the quarter ended Jun 30, 2026 was 21.46% (quarter ended Mar 31, 2026), 37.91% (quarter ended Dec 31, 2025) and 28.54% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.82%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 18.33%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 26.96%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 43.05%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 34.72%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.70%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 30.39%
10 Takeda Pharmaceutical 2.74 Bn -23.77 Bn 5.10 Bn 14.87%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.87%
Mar 31, 2026 21.46%
Dec 31, 2025 37.91%
Sep 30, 2025 28.54%
Jun 30, 2025 23.80%
Mar 31, 2025 21.87%
Dec 31, 2024 40.71%
Sep 30, 2024 25.07%
Jun 30, 2024 18.85%
Mar 31, 2024 17.78%
Dec 31, 2023 18.42%
Sep 30, 2023 22.45%
Jun 30, 2023 13.07%
Mar 31, 2023 12.11%
Dec 31, 2022 37.54%
Sep 30, 2022 77.50%
Jun 30, 2022 12.99%
Mar 31, 2022 17.16%
Jun 30, 2021 20.71%
Mar 31, 2021 56.75%
API Access

Takeda Pharmaceutical FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=TAK&period=max&api_key=YOUR_API_KEY